Sean Maduck
2019
In 2019, Sean Maduck earned a total compensation of $2.2M as Senior Vice President, Commercial at Corcept Therapeutics, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $308,881 |
|---|---|
| Option Awards | $1,476,276 |
| Salary | $456,133 |
| Total | $2,241,290 |
Maduck received $1.5M in option awards, accounting for 66% of the total pay in 2019.
Maduck also received $308.9K in bonus and $456.1K in salary.
Rankings
In 2019, Sean Maduck's compensation ranked 5,347th out of 13,971 executives tracked by ExecPay. In other words, Maduck earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,347 out of 13,971 | 62nd |
Division Manufacturing | 1,993 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 705 out of 2,200 | 68th |
Industry group Drugs | 592 out of 1,886 | 69th |
Industry Pharmaceutical Preparations | 439 out of 1,398 | 69th |
Source: SEC filing on April 27, 2020.
Maduck's colleagues
We found three more compensation records of executives who worked with Sean Maduck at Corcept Therapeutics in 2019.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019